Suppr超能文献

卒中中心认证对远程卒中环境下溶栓时间指标的影响。

Impact of Stroke Center Certification on Thrombolysis Time Metrics in Telestroke Setting.

作者信息

Almallouhi Eyad, Ajinkya Shaun, Rahwan Mohamad, Holmstedt Christine A, Al Kasab Sami

机构信息

Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.

出版信息

Telemed J E Health. 2021 Feb;27(2):167-171. doi: 10.1089/tmj.2020.0020. Epub 2020 May 12.

Abstract

Previous studies have shown that primary stroke centers (PSCs) have shorter door to needle (DTN) time than non-PSCs hospitals. We aimed to validate these findings in a high-volume telestroke network. The prospectively maintained data on all consecutive stroke patients who received intravenous alteplase (tissue plasminogen activator [tPA]) between July 2016 and November 2019 through a large telestroke program in Southeast United States was reviewed. Wilcoxon Rank-sum (Mann-Whitney) test was used to compare median times between different groups. Multivariate logistic regression model was used to assess the association between presenting to PSC and having DTN ≤45 and ≤60 min. During the study period, 1,517 patients received tPA, 874 (57.6%) at PSC sites. There were more white patients in the PSC group (64.3%) compared to non-PSC group (58%) (p < 0.001). Other characteristics were similar in patients in both groups. Time metrics were as follows, Door to telestroke page: 16 min versus 13 min (p < 0.001), telestroke page to tPA recommendation: 23 min versus 22 min (p = 0.975), tPA recommendation to tPA bolus administration: 13 min versus 10 min (p < 0.001), and DTN 58 min versus 49 min (p < 0.001) at non-PSC and PSC sites, respectively. On multivariate analysis, there were significantly higher odds for achieving a DTN ≤45 min (OR 2.8, 95% CI 1.8-4.4, p < 0.001) and DTN ≤60 min (OR 3, 95% CI 2.1-4.3, p < 0.001) in the PSC group. In our study, PSCs had better performance in the procedural metrics for tPA administration than non-PSCs in a large contemporary telestroke cohort.

摘要

先前的研究表明,初级卒中中心(PSC)的门到针(DTN)时间比非PSC医院更短。我们旨在通过一个大容量远程卒中网络验证这些发现。回顾了2016年7月至2019年11月期间,通过美国东南部一个大型远程卒中项目接受静脉注射阿替普酶(组织纤溶酶原激活剂[tPA])的所有连续性卒中患者的前瞻性维护数据。采用Wilcoxon秩和(Mann-Whitney)检验比较不同组之间的中位数时间。使用多变量逻辑回归模型评估就诊于PSC与DTN≤45分钟和≤60分钟之间的关联。在研究期间,1517例患者接受了tPA治疗,其中874例(57.6%)在PSC机构。与非PSC组(58%)相比,PSC组白人患者更多(64.3%)(p<0.001)。两组患者的其他特征相似。时间指标如下,到达远程卒中呼叫的时间:16分钟对13分钟(p<0.001),远程卒中呼叫至tPA推荐时间:23分钟对22分钟(p=0.975),tPA推荐至tPA推注给药时间:13分钟对10分钟(p<0.001),非PSC和PSC机构的DTN分别为58分钟对49分钟(p<0.001)。多变量分析显示,PSC组实现DTN≤45分钟(OR 2.8,95%CI 1.8-4.4,p<0.001)和DTN≤60分钟(OR 3,95%CI 2.1-4.3,p<0.001)的几率显著更高。在我们的研究中,在一个大型当代远程卒中队列中,PSC在tPA给药的程序指标方面比非PSC表现更好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验